BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 31536851)

  • 21. Coronary heart disease mortality in treated familial hypercholesterolaemia: Update of the UK Simon Broome FH register.
    Humphries SE; Cooper JA; Seed M; Capps N; Durrington PN; Jones B; McDowell IFW; Soran H; Neil HAW;
    Atherosclerosis; 2018 Jul; 274():41-46. PubMed ID: 29751283
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Familial hypercholesterolaemia: Experience of a tertiary paediatric lipid clinic.
    Yeung J; Chisholm K; Spinks C; Srinivasan S
    J Paediatr Child Health; 2021 Aug; 57(8):1201-1207. PubMed ID: 33830584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heterozygous familial hypercholesterolaemia in childhood: cardiovascular risk prevention.
    van der Graaf A; Kastelein JJP; Wiegman A
    J Inherit Metab Dis; 2009 Dec; 32(6):699. PubMed ID: 19898954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreasing the Cholesterol Burden in Heterozygous Familial Hypercholesterolemia Children by Dietary Plant Stanol Esters.
    Vuorio A; Kovanen PT
    Nutrients; 2018 Dec; 10(12):. PubMed ID: 30513705
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Familial hypercholesterolaemia in children and adolescents: a new paediatric model of care.
    Martin AC; Coakley J; Forbes DA; Sullivan DR; Watts GF
    J Paediatr Child Health; 2013 Apr; 49(4):E263-72. PubMed ID: 23252991
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC).
    ; Vallejo-Vaz AJ; De Marco M; Stevens CAT; Akram A; Freiberger T; Hovingh GK; Kastelein JJP; Mata P; Raal FJ; Santos RD; Soran H; Watts GF; Abifadel M; Aguilar-Salinas CA; Al-Khnifsawi M; AlKindi FA; Alnouri F; Alonso R; Al-Rasadi K; Al-Sarraf A; Ashavaid TF; Binder CJ; Bogsrud MP; Bourbon M; Bruckert E; Chlebus K; Corral P; Descamps O; Durst R; Ezhov M; Fras Z; Genest J; Groselj U; Harada-Shiba M; Kayikcioglu M; Lalic K; Lam CSP; Latkovskis G; Laufs U; Liberopoulos E; Lin J; Maher V; Majano N; Marais AD; März W; Mirrakhimov E; Miserez AR; Mitchenko O; Nawawi HM; Nordestgaard BG; Paragh G; Petrulioniene Z; Pojskic B; Postadzhiyan A; Reda A; Reiner Ž; Sadoh WE; Sahebkar A; Shehab A; Shek AB; Stoll M; Su TC; Subramaniam T; Susekov AV; Symeonides P; Tilney M; Tomlinson B; Truong TH; Tselepis AD; Tybjærg-Hansen A; Vázquez-Cárdenas A; Viigimaa M; Vohnout B; Widén E; Yamashita S; Banach M; Gaita D; Jiang L; Nilsson L; Santos LE; Schunkert H; Tokgözoğlu L; Car J; Catapano AL; Ray KK;
    Atherosclerosis; 2018 Oct; 277():234-255. PubMed ID: 30270054
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Familial Hypercholesterolaemia in the Era of Genetic Testing.
    Hughes DP; Viljoen A; Wierzbicki AS
    Curr Cardiol Rep; 2016 May; 18(5):42. PubMed ID: 27002618
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness of genetic cascade screening for familial hypercholesterolaemia using a centrally co-ordinated clinical service: an Australian experience.
    Bell DA; Pang J; Burrows S; Bates TR; van Bockxmeer FM; Hooper AJ; O'Leary P; Burnett JR; Watts GF
    Atherosclerosis; 2015 Mar; 239(1):93-100. PubMed ID: 25585028
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Familial hypercholesterolaemia: optimum treatment strategies.
    Ballantyne CM
    Int J Clin Pract Suppl; 2002 Jul; (130):22-6. PubMed ID: 12296605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atherosclerosis in cholesterol-fed rabbits and in homozygous and heterozygous LDL receptor-deficient humans.
    Thompson GR
    Atherosclerosis; 2018 Sep; 276():148-154. PubMed ID: 30064057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of patients with familial hypercholesterolaemia.
    Reiner Ž
    Nat Rev Cardiol; 2015 Oct; 12(10):565-75. PubMed ID: 26076948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipoprotein profile assessed by 2D-1H-NMR and subclinical atherosclerosis in children with familial hypercholesterolaemia.
    Rodríguez-Borjabad C; Ibarretxe D; Girona J; Ferré R; Feliu A; Amigó N; Guijarro E; Masana L; Plana N;
    Atherosclerosis; 2018 Mar; 270():117-122. PubMed ID: 29407879
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Landmark position paper on paediatric familial hypercholesterolaemia from the EAS Consensus Panel.
    Stock J
    Atherosclerosis; 2015 Sep; 242(1):277-80. PubMed ID: 26232168
    [No Abstract]   [Full Text] [Related]  

  • 34. Familial hypercholesterolaemia: a model of care for Australasia.
    Watts GF; Sullivan DR; Poplawski N; van Bockxmeer F; Hamilton-Craig I; Clifton PM; O'Brien R; Bishop W; George P; Barter PJ; Bates T; Burnett JR; Coakley J; Davidson P; Emery J; Martin A; Farid W; Freeman L; Geelhoed E; Juniper A; Kidd A; Kostner K; Krass I; Livingston M; Maxwell S; O'Leary P; Owaimrin A; Redgrave TG; Reid N; Southwell L; Suthers G; Tonkin A; Towler S; Trent R;
    Atheroscler Suppl; 2011 Oct; 12(2):221-63. PubMed ID: 21917530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Real-life LDL-C treatment goals achievement in patients with heterozygous familial hypercholesterolemia in the Czech Republic and Slovakia: Results of the PLANET registry.
    Vrablik M; Raslová K; Vohnout B; Blaha V; Satny M; Kyselak O; Vaclova M; Urbanek R; Maskova J; Soska V; Freiberger T
    Atherosclerosis; 2018 Oct; 277():355-361. PubMed ID: 30270071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reaching detection targets in familial hypercholesterolaemia: Comparison of identification strategies.
    Wald DS; Bestwick JP
    Atherosclerosis; 2020 Jan; 293():57-61. PubMed ID: 31837509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Familial hypercholesterolaemia: a pressing issue for European health care.
    Brice P; Burton H; Edwards CW; Humphries SE; Aitman TJ
    Atherosclerosis; 2013 Dec; 231(2):223-6. PubMed ID: 24267231
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Managing homozygous familial hypercholesterolaemia from cradle to grave.
    Thompson GR
    Atheroscler Suppl; 2015 May; 18():16-20. PubMed ID: 25936299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integrated guidance to enhance the care of children and adolescents with familial hypercholesterolaemia: Practical advice for the community clinician.
    Horton AE; Martin AC; Srinivasan S; Justo RN; Poplawski NK; Sullivan D; Brett T; Chow CK; Nicholls SJ; Pang J; Watts GF;
    J Paediatr Child Health; 2022 Aug; 58(8):1297-1312. PubMed ID: 35837752
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Belgian consensus strategy to identify familial hypercholesterolaemia in the coronary care unit and its subsequent cascade screening and treatment: BEL-FaHST (The BELgium Familial Hypercholesterolaemia STrategy).
    Descamps OS; Van Caenegem O; Hermans MP; Balligand JL; Beauloye C; Bondue A; Carlier S; Castermans E; Chenot F; Claeys M; De Block C; de Leener A; De Meester A; Demeure F; De Raedt H; Desmet W; Elegeert I; Guillaume M; Hoffer E; Kacenelenbogen R; Lancellotti P; Langlois M; Leone A; Mertens A; Paquot N; Vanakker O; Vanoverschelde JL; Verhaegen A; Vermeersch P; Wallemacq C; Rietzschel E;
    Atherosclerosis; 2018 Oct; 277():369-376. PubMed ID: 30270073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.